KRYS Krystal Biotech Inc

Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference

Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference

PITTSBURGH, Feb. 26, 2025 (GLOBE NEWSWIRE) -- . (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the TD Cowen 45th Annual Health Care Conference on March 4, 2025, in Boston. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 1:50 pm ET and host investor meetings throughout the day.

A webcast of the presentation will be available beginning at 1:50 pm ET on Tuesday, March 4, 2025 and will be posted on the Investors section of the Company’s .

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK® is the Company’s first commercial product, the first-ever redosable gene therapy, and the first medicine approved by the FDA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit , and follow @KrystalBiotech on and (formerly Twitter).

CONTACT

Investors and Media:

Stéphane Paquette

Krystal Biotech



EN
26/02/2025

Underlying

KRYSKrystal Biotech Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Krystal Biotech Inc

Free Trial
KRYS Krystal Biotech...

Krystal Biotech Inc: 2 directors

Two Directors at Krystal Biotech Inc sold/sold after exercising options 50,000 shares at 177.791USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direct...

KRYS KRYSTAL BIOTECH INC
11h / 22m 11h / 22m 1 EN
 PRESS RELEASE
Free
KRYS Krystal Biotech...

Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Tr...

Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa EC approval decision anticipated in second quarter of 2025 PITTSBURGH, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today welcomed the European Medicines Agency's (EMA’s)  that its Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for the European Commission (EC) to approve VYJUVEK® (beremagene geperpavec-svdt, or B-VEC) for the treatment of wounds in...

February 28, 2025 1 EN
 PRESS RELEASE
Free
KRYS Krystal Biotech...

Krystal Biotech to Present at TD Cowen 45th Annual Health Care Confere...

Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference PITTSBURGH, Feb. 26, 2025 (GLOBE NEWSWIRE) -- . (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the TD Cowen 45th Annual Health Care Conference on March 4, 2025, in Boston. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 1:50 pm ET and host investor meetings throughout the day. A webcast of the presentation will be available beginning at 1:50 pm ET on Tuesday, March 4, 2025 and wil...

February 26, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 46.11
OXY Occidental Petr...
SHAK Shake Shack In... ... (+22)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

OXY OCCIDENTAL PETROLEUM CORPORATION
SHAK SHAKE SHACK INC. CLASS A
SKT TANGER FACTORY OUTLET CENTERS INC.
RGR STURM RUGER & COMPANY INC.
POWI POWER INTEGRATIONS INC.
MD MEDNAX INC.
ICLR ICON PLC
HAS HASBRO INC.
CRAI CHARLES RIVER ASSOCIATES INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
AVNW AVIAT NETWORKS
LKO LAKES OIL N.L.
MX MAGNACHIP SEMICONDUCTOR CORP.
BELFB BEL FUSE INC. CL B
LAUR LAUREATE EDUCATION INC. CLASS A
PMTS CPI CARD GROUP
KRYS KRYSTAL BIOTECH INC
SWTX SPRINGWORKS THERAPEUTICS
CSTM CONSTELLIUM SE CLASS A
AM ANTERO MIDSTREAM CORP.
CADL CANDEL THERAPEUTICS INC
FTAI FORTRESS TRANSN & INFRAS INVS LLC
02/21/25 February 21, 2025 1 EN
 PRESS RELEASE
Free
KRYS Krystal Biotech...

Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial ...

Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023 Full year revenues increased 473% to $290.5 million versus 2023 CFF TDN granted full sanctioning of KB407 Phase 1 protocol Strong balance sheet, ending the quarter with $749.6 million in cash and investments PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today reported financial results for the fourth quarter and full year ending Decem...

February 19, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch